A1IZJ

(5~{S})-5-[[[5-[2-chloranyl-3-[2-chloranyl-3-[6-methoxy-5-[[[(2~{S})-5-oxidanylidenepyrrolidin-2-yl]methylamino]methyl]pyrazin-2-yl]phenyl]phenyl]-3-methoxy-pyrazin-2-yl]methylamino]methyl]pyrrolidin-2-one

Created:2025-01-22
Last modified:  2025-06-18

Find related ligands:

Chemical Details

Formal Charge0
Atom Count84
Chiral Atom Count2
Bond Count89
Aromatic Bond Count24
2D diagram of A1IZJ

Chemical Component Summary

Name(5~{S})-5-[[[5-[2-chloranyl-3-[2-chloranyl-3-[6-methoxy-5-[[[(2~{S})-5-oxidanylidenepyrrolidin-2-yl]methylamino]methyl]pyrazin-2-yl]phenyl]phenyl]-3-methoxy-pyrazin-2-yl]methylamino]methyl]pyrrolidin-2-one
Systematic Name (OpenEye OEToolkits)(5~{S})-5-[[[5-[2-chloranyl-3-[2-chloranyl-3-[6-methoxy-5-[[[(2~{S})-5-oxidanylidenepyrrolidin-2-yl]methylamino]methyl]pyrazin-2-yl]phenyl]phenyl]-3-methoxy-pyrazin-2-yl]methylamino]methyl]pyrrolidin-2-one
FormulaC34 H36 Cl2 N8 O4
Molecular Weight691.607
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESCACTVS3.385COc1nc(cnc1CNC[CH]2CCC(=O)N2)c3cccc(c3Cl)c4cccc(c4Cl)c5cnc(CNC[CH]6CCC(=O)N6)c(OC)n5
SMILESOpenEye OEToolkits2.0.7COc1c(ncc(n1)c2cccc(c2Cl)c3cccc(c3Cl)c4cnc(c(n4)OC)CNCC5CCC(=O)N5)CNCC6CCC(=O)N6
Canonical SMILESCACTVS3.385 COc1nc(cnc1CNC[C@@H]2CCC(=O)N2)c3cccc(c3Cl)c4cccc(c4Cl)c5cnc(CNC[C@@H]6CCC(=O)N6)c(OC)n5
Canonical SMILESOpenEye OEToolkits2.0.7 COc1c(ncc(n1)c2cccc(c2Cl)c3cccc(c3Cl)c4cnc(c(n4)OC)CNC[C@@H]5CCC(=O)N5)CNC[C@@H]6CCC(=O)N6
InChIInChI1.06 InChI=1S/C34H36Cl2N8O4/c1-47-33-27(15-37-13-19-9-11-29(45)41-19)39-17-25(43-33)23-7-3-5-21(31(23)35)22-6-4-8-24(32(22)36)26-18-40-28(34(44-26)48-2)16-38-14-20-10-12-30(46)42-20/h3-8,17-20,37-38H,9-16H2,1-2H3,(H,41,45)(H,42,46)/t19-,20-/m0/s1
InChIKeyInChI1.06 OIIOPWHTJZYKIL-PMACEKPBSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank IDDB21520 
NameEvixapodlin
Groups investigational
DescriptionEvixapodlin is a small molecule drug. Evixapodlin is under investigation in clinical trial NCT04049617 (Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors). Evixapodlin has a monoisotopic molecular weight of 690.22 Da.
SynonymsEvixapodlin
CategoriesImmune Checkpoint Inhibitors
CAS number2374856-75-2

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Programmed cell death 1 ligand 1MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDL...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 139415912
ChEMBL CHEMBL5095237